Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 21 Gastrointestinal 18 Genitourinary 12 Gynecologic 11 CNS 8 Other hematologic neoplasm 7 Other solid neoplasm 4 Lymphoid 4 Head & Neck 3 Sarcoma 2 Dermatologic 2 Tumor-Agnostic 1 Thoracic 1 Plasma cell 1 Other neoplasm 1 Myeloid 1 Endocrine 1 Classical hematology 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 1167 Cisplatin 889 Pemetrexed 845 pembrolizumab 622 Paclitaxel 608 Docetaxel 539 Gemcitabine 428 Radiotherapy 390 Erlotinib Hydrochloride 381 Nivolumab 344 Bevacizumab 337 Etoposide 296 durvalumab 264 Drug Therapy 260 osimertinib 236 atezolizumab 224 Radiosurgery 194 Gefitinib 186 Vinorelbine 149 Magnetic Resonance Spectroscopy 131 Ipilimumab 129 130-nm albumin-bound paclitaxel 124 Cetuximab 113 Blood Specimen Collection 106 anlotinib 105 tislelizumab 103 Topotecan 103 Specimen Handling 102 Surgical Procedures, Operative 101 Cyclophosphamide 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Testing × Thoracic × Clear all

NCT02299622 2021-03-19

Personalized Sequence for Thoracic, Esophageal, and H&N Cancer

Samsung Medical Center

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡